News | Imaging | July 22, 2015

ViewRay's MRIdian System Featured at AAPM 2015

Users presented on online adaptive and real-time motion tracking with MRI-guided radiation therapy

July 22, 2015 - ViewRay's MRIdian System, the world's first and only magnetic resonance imaging (MRI)-guided radiation therapy system, was featured during the 2015 annual meeting of the American Association of Physicists in Medicine (AAPM). This year's meeting was held July 12-16 in Anaheim, California.

The MRIdian System is designed to improve the accuracy of cancer treatments through a patented combination of simultaneous MRI and radiation therapy delivery. With continuous soft-tissue imaging, clinicians can clearly see the cancer target, monitor where the actual radiation dose is being delivered, and adapt to changes in the patient's anatomy – all in real time while the patient is on the treatment table. This provides a more precise and personalized cancer treatment.

AAPM selected 20 abstracts reporting on real-world clinical experience with MR-guided radiation therapy from three MRIdian sites. These oral and poster presentations included the "Best in Physics" presentation: An Integrated Model-Based Intrafractional Organ Motion Tracking Approach with Dynamic MRI in Head and Neck Radiotherapy. The presentations covered a wide range of topics including on-table adaptive treatments, real-time MR motion tracking, online Monte Carlo dose calculations and several relating to system quality assurance.

Additionally, a number of physicist users of the MRIdian System presented on their experience in ViewRay's booth. Clinical applications experts from ViewRay were also available in the booth to demonstrate treatment planning and delivery functionality of the system.

For more information: www.viewray.com

Related Content

Mayo Clinic Installing First FDA-Approved Clinical 7T MRI
News | Magnetic Resonance Imaging (MRI) | October 20, 2017
Mayo Clinic in Rochester, Minn., will have the first clinical 7-Tesla magnetic resonance imaging (MRI) scanner in North...
Xstrahl Photoelectric Therapy System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | October 20, 2017
Xstrahl announced that its Photoelectric Therapy System has received U.S. Food and Drug Administration (FDA) 510(k)...
Cleveland Clinic Researchers Reveal Biomarker for Guiding Prostate Cancer Treatment
News | Prostate Cancer | October 17, 2017
October 17, 2017 — Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-r
IBA Announces First Use of Gating With Active Scanning Proton Therapy in Italy
News | Proton Therapy | October 17, 2017
October 17, 2017 — The Trento Azienda Provinciale per i Servizi Sanitari (APSS) and IBA announced the successful comp
Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy
News | Radiation Therapy | October 16, 2017
Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator...
Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation Therapy, MRI guided RT.
Sponsored Content | Webinar | Radiation Therapy | October 13, 2017
The webinar "Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation" will be presented by Par
FDA Clears Siemens Magnetom Terra 7T MRI Device

FDA Clears Siemens Magnetom Terra 7T MRI Device

Technology | Magnetic Resonance Imaging (MRI) | October 12, 2017
The U.S. Food and Drug Administration (FDA) cleared the first 7 Tesla (7T) magnetic resonance imaging (MRI) device,...
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI) | October 11, 2017
October 11, 2017 — MR Solutions took their cryogen-free preclinical multimodality...
Overlay Init